BRM4 Shown to Triple Natural Killer (NK) Cell Activity

November 17, 2008

Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC).

BRM4 ® in a 250mg dosage, 60 count bottle, has been available through physicians for over 10 years. In pre-clinical studies, the power of BRM4 ® multiplies T cell levels up to 200%. The enhanced activity of helper T cells promotes the proliferation of cytotoxic T and B cells for essential immune support. Helper T cells also signal plasma B cells when they encounter their cognate antigen to secure a health production of antibodies. Furthermore, BRM4 ® supports the body’s natural production of cytokines to control inflammatory response.(Los Angeles, CA) November 17, 2008 – Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC), has been clinically shown to triple Natural Killer (NK) cell activity, increase T and B lymphocytes and demonstrate vital antioxidant and anti-inflammatory action.                                                                                     

RBAC, a polysaccharide dietary fiber derived from rice bran, is modified by a Shiitake mushroom enzyme using a patented biotechnology process. As an immune modulator, BRM4 ® retains its effectiveness over time. Clinical trials have shown BRM4 ® is safe with no side effects. In over 12 years of worldwide use, there have been no reported cases of drug interactions. BRM4 ® is recognized as the gold standard immune product worldwide for people with seriously compromised immune systems.

Double Strength BRM4 ® is now available to health professionals in the U.S. For more product and ordering information call 877-4DHDMED (877-434-3633) or email info@dhdmed.com

Los Angeles-based Daiwa Health Development, Inc. is a subsidiary of Daiwa Pharmaceutical Co. Ltd. based in Tokyo, Japan. Daiwa has become a leading research and manufacturing company, striving to create new value in the field of bioscience. Daiwa focuses on the manufacturing and distribution of nutraceuticals, functional foods and cosmetics.
 




Leave a comment

Comments will be approved before showing up.


Also in News

Supporting the Immune System

November 05, 2018

Research: Cheatham referenced several clinical trials that Daiwa kept a close eye on surrounding Rice Bran Arabinoxylan Compound (RBAC), the active ingredients in the company's BRM4 product.

Continue Reading

STUDIES PROVE RBAC IS A NEW AUTHENTIC SMART FOOD

August 13, 2018

To understand RBAC, you need to understand the immune system. Dr. John Lewis, Ph.D. CEO and Co-founder of Nurish.Me, LLC broke it down in a presentation titled, “The Immunomodulatory and Anti-Senescent Effects of Arabinoxylan among Healthy Adults and Patients with Chronic Illness.”
 
According to his findings, Arabinoxylan may be nature’s perfect counter to immunosenescence, a process that increases susceptibility to chronic and infectious diseases recognized as the aging phenotype.

Continue Reading

Radio Interview: "The Next Generation of Krill Oil"

July 14, 2018

Topic: Daiwa "Superba" - next generation of Krill Oil.
Guest:  Nils Hoem:  Chief scientist at AKER Bio Marine.

Continue Reading

DAIWA HEALTH DEVELOPMENT

SAVE 20% off on your first order by signing up to our e-newsletter and get the latest products, special events and promotional offers delivered to your inbox.  A confirmation email will be sent to you with the promotional code.

Wholesale Sign up